Qingdao Haier Biomedical Co (SHSE:688139) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Qingdao Haier Biomedical Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Qingdao Haier Biomedical Co's long-term debt to total assets ratio stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Qingdao Haier Biomedical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Qingdao Haier Biomedical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co LT-Debt-to-Total-Asset Chart

Qingdao Haier Biomedical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Qingdao Haier Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Qingdao Haier Biomedical Co LT-Debt-to-Total-Asset Calculation

Qingdao Haier Biomedical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	8.689	/	5525.683
	=	0.00

Qingdao Haier Biomedical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	8.732	/	5686.836
	=	0.00

Qingdao Haier Biomedical Co (SHSE:688139) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Qingdao Haier Biomedical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.1 Haier Road, Branding Building, Qingdao, CHN, 266101

Website

http://www.haiermedical.com

Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.

Executives

Zhang Jiang Tao	Core technical personnel
Liu Ji Yuan	Core technical personnel
Teng Pei Kun	Core technical personnel
Wang Guang Sheng	senior management
Gong Yi	Director
Huang Yan Li	senior management
Chen Hai Tao	Senior management, core technical personnel
Liu Zhan Jie	Directors, senior managers, core technical personn
Mo Rui Juan	senior management
Wang Wen Fu	Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines